Join Now

Yearly Archives: 2026

Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease

For Fabry patients, a potential path to converting 130 clinic visits into one treatment every five years.

Posted in BioUtah News | Tagged | Comments Off on Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease

BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including proportionality, arm span and body mass index, building on over 10,000 patient-years of data  

Posted in BioUtah News | Tagged | Comments Off on BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Posted in BioUtah News | Tagged | Comments Off on Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort

Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.

Posted in BioUtah News | Tagged | Comments Off on Springboard Enterprises Announces 2026 Women’s Health Accelerator Cohort

Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care

Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’

Posted in BioUtah News | Tagged , | Comments Off on Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care

Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit

The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation

Posted in BioUtah News | Comments Off on Utah’s Life Sciences Community Takes Off at the 2026 Entrepreneur & Investor Summit

ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG

ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG

Posted in BioUtah News | Tagged | Comments Off on ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG

Myriad Commercially Launches Precise MRD with Select Community Oncologists

Launch Represents Significant Step to Broader Commercialization

Posted in BioUtah News | Tagged | Comments Off on Myriad Commercially Launches Precise MRD with Select Community Oncologists

RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox

RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox

Posted in BioUtah News | Tagged | Comments Off on RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox

FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test

Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry

Posted in BioUtah News | Tagged | Comments Off on FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test

ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

Posted in BioUtah News | Tagged | Comments Off on ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

Posted in BioUtah News | Tagged | Comments Off on Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization